Dose-escalation Study of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy
Clinical trial NCT02925000 · COMPLETED
Trial details
- NCT number
- NCT02925000
- Sponsor
- Taiwan Liposome Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-19
- Primary completion
- 2020-10-06
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.